(Q41463841)

1 October 2017

1 reference

title

Mechanisms of tamoxifen resistance in the treatment of advanced breast cancer (English)

1 reference

1 October 2017

1 reference

Lykkesfeldt AE

1

1 reference

1 October 2017

publication date

1 January 1996

1 reference

1 October 2017

1 reference

1 October 2017

volume

35 Suppl 5

1 reference

1 October 2017

page(s)

9-14

1 reference

Hormones in breast cancer: Update 1978

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F02841869609083961

Tamoxifen in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609083961

Regulation of insulin-like growth factors by antiestrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609083961

Acquired tamoxifen resistance in human breast cancer and reduced intra-tumoral drug concentration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609083961

P-glycoprotein and resistance to tamoxifen.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609083961

Measurement of steroid hormone receptors in breast cancer patients on tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609083961

Physicochemical and genetic evidence for specific antiestrogen binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609083961

Selection and characterization of a breast cancer cell line resistant to the antiestrogen LY 117018.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609083961

Indirect mechanism of oestradiol stimulation of cell proliferation of human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609083961

Characterisation of a tamoxifen-resistant variant of the ZR-75-1 human breast cancer cell line (ZR-75-9a1) and ability of the resistant phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609083961

Type I IGF receptor and acquired tamoxifen resistance in oestrogen-responsive human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609083961

Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast-cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609083961

Human breast cancer cell lines resistant to pure anti-estrogens are sensitive to tamoxifen treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609083961

Estrogen receptor variants in clinical breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609083961

Molecular aspects of estrogen receptor variants in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609083961

Differential expression of estrogen receptor mRNA splice variants in the tamoxifen resistant human breast cancer cell line, MCF-7/TAMR-1 compared to the parental MCF-7 cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609083961

Identification of a Dominant Negative Form of the Human Estrogen Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609083961

Truncated forms of DNA-binding estrogen receptors in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609083961

Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609083961

Interaction of proteins with transcriptionally active estrogen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609083961

Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609083961

Prognostic significance of circulating P53 antibodies in patients undergoing surgery for locoregional breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609083961

High-affinity anti-oestrogen binding site distinct from the oestrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609083961

Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609083961

10.3109/02841869609083961

21 January 2018

Identifiers

DOI

1 reference

1 October 2017

1 reference